Out-of-hospital coagulation monitoring and management

Journal of Thrombosis and Thrombolysis

Volumn 7, Issue 2, 1999, Pages 191-194

  Ansell, Jack E ^a  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; PROTHROMBIN; WARFARIN;

BLEEDING; BLOOD CLOTTING; BRAIN HEMORRHAGE; COMORBIDITY; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HEALTH CARE MANAGEMENT; HEART ATRIUM FIBRILLATION; HOME MONITORING; HUMAN; PATIENT MONITORING; PATIENT SATISFACTION; PRIORITY JOURNAL; PROTHROMBIN TIME; RISK BENEFIT ANALYSIS; SHORT SURVEY; THROMBOSIS;

ANTICOAGULANTS; DRUG MONITORING; HUMANS; OUTPATIENTS; PRACTICE GUIDELINES; PROTHROMBIN TIME; QUALITY ASSURANCE, HEALTH CARE; SELF CARE;

EID: 0032904830     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008893706046     Document Type: Short Survey

References (47)

1. Ansell JE. Anticoagulation management as a risk factor for adverse events: Grounds for improvement. J Thromb Thrombolys 1997, Suppl, in press.
2. Fihn SD, McDonell M, Martin D, et al. Risk factors for complications of chronic anticoagulation: A multicenter study. Ann Intern Med 1993;118:511-520.
3. Van der Meer FJ, Rosendaal FR, Vandenbrouke JP, Briet E. Bleeding complications in oral anticoagulant therapy: An analysis of risk factors. Arch Intern Med 1993;153:1557-1562.
4. Cannegieter SC, Rosendaal Fr, Wintzen AR, van der Meer FJM, Vandenbroucke JP, Briet E. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med 1995;33:11-17.
5. Hylek EM, Singer DE. Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med 1994;120:897-902.
6. Hylek EM, Skates SJ, Sheehan MA, Singer DE. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. N Engl J Med 1996;335:540-546.
7. Petitti DB, Strom BL, Melmon KL. Prothrombin time ratio and other factors associated with bleeding in patients treated with warfarin. J Clin Epidemiol 1989;42:759-764.
8. Landefeld CS, Rosenblatt MW, Goldman L. Bleeding in outpatients treated with warfarin: Relation to the prothrombin time and important remedial lesions. Am J Med 1989; 87:153-159.
9. Landefeld CS, Cook F, Flatley M, Weisberg M, Goldman L. Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapy. Am J Med 1987;82:703-713.
10. Landefeld CS, Goldman L. Major bleeding in outpatients treated with warfarin: Incidence and prediction by factors known at the start of outpatient therapy. Am J Med 1989;87:144-152.
11. Launbjerg J, Egeblad H, Heaf J, Nielsen NH, Fugleholm AM, Ladefoged K. Bleeding complications to oral anticoagulant therapy: Multivariate analysis of 1010 treatment years in 551 outpatients. J Intern Med 1991;229:351-355.
12. Charney R, Leddomado E, Rose DN, Fuster V. Anticoagulation clinics and the monitoring of anticoagulant therapy. Int J Cardiol 1988;18:197-206.
13. Gitter MJ, Jaeger TM, Petterson TM, Gersh BJ, Silverstein MD. Bleeding and thromboembolism during anticoagulant therapy: A population-based study in Rochester, Minnesota. Mayo Clin Proc 1995;70:725-733.
14. Palareti G, Leali N, Coccheri S, et al. Bleeding complications of oral anticoagulant treatment: An inception-cohort, prospective collaborative study (ISCOAT). Lancet 1996;348: 423-428.
15. Stroke Prevention in Atrial Fibrillation Investigators. Bleeding during antithrombotic therapy in patients with atrial fibrillation. Arch Intern Med 1996;156:409-416.
16. Fihn SD, Callahan CM, Martin DC, et al. The risk for and severity of bleeding complication in elderly patients treated with warfarin. Ann Intern Med 1996;124:970-979.
17. Coon WW, Willis PW Hemorrhagic complications of anticoagulant therapy. Arch Intern Med 1974;133:386-392.
18. Davis FB, Estruch MT, Samson-Cervera EB, et al. Management of anticoagulation in outpatients: Experience with an anticoagulation service in a municipal hospital setting. Arch Intern Med 1977;137:197-202.
19. Forfar JC. Prediction of hemorrhage during long-term oral coumarin anticoagulation by excessive prothrombin ratio. Am Heart J 1982;103:445-446.
20. Errichetti AM, Holden A, Ansell J. Management of oral anticoagulant therapy: Experience with an anticoagulation clinic. Arch Intern Med 1984;144:1966-1968.
21. Petty GW, Lennihan L, Mohr JP, et al. Complications of long-term anticoagulation. Ann Neurol 1988;23:570-574.
22. Bussey HI, Rospond RM, Quandt CM, Clark GM. The safety and effectiveness of long-term warfarin therapy in an anticoagulation clinic. Pharmacotherapeutica 1989;9:214-219.
23. Gurwitz J, Goldberg R, Holden A, Knapic N, Ansell J. Age-related risks of long-term oral anticoagulant therapy. Arch Intern Med 1988;148:1733-1736.
24. Sixty Plus Reinfarction Study Research Group. Risks of long-term oral anticoagulant therapy in elderly patients after myocardial infarction. Lancet 1982;1:64-68.
25. McInnes GT, Helenglass G. The performance of clinics for outpatient control of anticoagulation. J R Coll Phys Lond 1987;21:42-45.
26. Wickramasinghe LSP, Basu SK, Bansal SK. Long-term oral anticoagulant therapy in elderly patients. Age Ageing 1988;17:388-396.
27. Joglekar M, Mohanaruban K, Bayer AJ, Pathy MSJ. Can old people on oral anticoagulants be safely managed as outpatients? Postgrad Med J 1988;64:775-777.
28. Isaacs C, Paltiel O, Blake G, Beaudet M, Conochie L, Leclerc J. Age-associated risks of prophylactic anticoagulation in the setting of hip fracture. Am J Med 1994;96:487-491.
29. Ansell JE, Hughes R. Evolving models of warfarin management: Anticoagulation clinics, patient self-monitoring, and patient self-management. Am Heart J 1996;132:1095-1100.
30. Ansell JE, Buttaro ML, Voltis Thomas O, Knowlton CH, Anticoagulation Guidelines Task Force. Consensus guidelines for coordinated outpatient oral anticoagulation therapy management. Ann Pharmacother 1997;31:604-615.
31. Leaning KE, Ansell JE. Advances in the monitoring of oral anticoagulation: Point-of-care testing, patient self-monitoring and patient self-management. J Thromb Thrombolys 1996;3:377-383.
32. Lucas FV, Duncan A, Jay R, et al. A novel whole blood capillary technique for measuring prothrombin time. Am J Clin Pathol 1987;88:442-446.
33. Yano Y, Kambayashi J, Murata K, et al. Bedside monitoring of warfarin therapy by a whole blood capillary coagulation monitor. Thromb Res 1992;66:583-590.
34. Weibert RT, Adler DS. Evaluation of a capillary whole blood prothrombin time measurement system. Clin Pharm 1989;8:864-867.
35. White RH, McCurdy SA, von Marensdorff H, Woodruff DE, Leftgoff L. Home prothrombin time monitoring after initiation of warfarin therapy. Ann Intern Med 1989:111:730-737.
36. Anderson D, Harrison L, Hirsh J. Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy. Arch Intern Med 1993;153:1441-1447.
37. Jennings I, Luddington RJ, Baglin T. Evaluation of the Ciba Corning Biotrack 512 coagulation monitor for the control of oral anticoagulation. J Clin Pathol 1991;44:950-953.
38. Tripodi A, Arbini A, Chantarangkul V, Bettega D, Mannucci PM. Are capillary whole blood coagulation monitors suitable for the control of oral anticoagulant treatment by the International Normalized Ratio? Thromb Haemostas 1993;70: 921-924.
39. McCurdy SA, White RH. Accuracy and precision of a portable anticoagulation monitor in a clinical setting. Arch Intern Med 1992;152:589-592.
40. Ansell J, Becker D, Andrew M, et al. Accurate and precise prothrombin time measurement in a multicenter anticoagulation trial employing patient self-testing. Blood 1995;86 (Suppl. 1):864a.
41. Andrew M, Marzinotto V, Adams M, Cimini C, Triplett D, LaDuca F. Monitoring of oral anticoagulant therapy in pediatric patients using a new microsample PT device. Blood 1995;86(Suppl. 1):863a.
42. Byeth RJ, Landefeld CS. Prevention of major bleeding in older patients treated with warfarin: Results of a randomized trial. J Gen Intern Med 1997;12:66.
43. Ansell J, Holden A, Knapic N. Patient self-management of oral anticoagulation guided by capillary fingerstick whole blood prothrombin times. Arch Intern Med 1989;149: 2509-2511.
44. Ansell J, Patel N, Ostrovsky D, Nozzolillo E, Peterson AM, Fish L. Long-term patient self-management of oral anticoagulation. Arch Intern Med 1995;155:2185-2189.
45. Bernardo A. Experience with patient self-management of oral anticoagulation. J Thromb Thrombolys 1996;2:321-325.
46. Horstkotte D, Piper C, Wiemer M, Schulte HD, Schultheiss H.-P. Improvement of prognosis by home prothrombin estimation in patients with life-long anticoagulant therapy. Eur Heart J 1996;17(Suppl.):230.
47. Piper C, Horstkotte D, Wiemer W, Schulte HD, Schultheiss H.-P. Optimization of oral anticoagulation following valve replacement: Results of prospective randomized study. Eur Heart J 1996;17(Suppl.):230.